Coya Therapeutics (COYA) Assets (2021 - 2026)
Coya Therapeutics' Assets came in at $47.31 million for Q2 2026, up 41.4% from $33.45 million a year earlier but down 11.2% from the prior quarter.
Powered by 
Analysis
Coya Therapeutics (COYA) Assets (2021 - 2026) Analysis & Trends
At the end of FY2025, Coya Therapeutics' Assets was $49.95 million, up 12.6% from FY2024.
- Assets has increased in each of the last four years, with a four-year compound annual growth rate of 79.7% (FY2021 to FY2025).
- Going back by year, Assets was $44.35 million in FY2024 (+7.5%), $41.26 million in FY2023 (+391.5%), $8.4 million in FY2022 (+75.2%) and $4.79 million in FY2021.
- The five-year range for quarterly Assets is $4.79 million (Q4 2021) to $53.27 million (Q1 2026).
- Year-over-year, Assets has increased for three consecutive quarters, with growth averaging 34.5% over the last eight quarters.
- The fastest year-over-year change in Assets over five years came in Q4 2023 (growth of 391.5%), and the weakest in Q2 2025 (a decline of 16.2%).
- Business Quant data shows COYA's Assets at $53.27 million (Q1 2026), $49.95 million (Q4 2025) and $32.04 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 201.06 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Coya Therapeutics | 96.17 Mn | -72.70 Mn | - | 47.31 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 47.31 Mn |
| Mar 31, 2026 | 53.27 Mn |
| Dec 31, 2025 | 49.95 Mn |
| Sep 30, 2025 | 32.04 Mn |
| Jun 30, 2025 | 33.45 Mn |
| Mar 31, 2025 | 38.40 Mn |
| Dec 31, 2024 | 44.35 Mn |
| Sep 30, 2024 | 35.55 Mn |
| Jun 30, 2024 | 39.94 Mn |
| Mar 31, 2024 | 37.39 Mn |
| Dec 31, 2023 | 41.26 Mn |
| Sep 30, 2023 | 11.90 Mn |
| Jun 30, 2023 | 14.47 Mn |
| Mar 31, 2023 | 17.42 Mn |
| Dec 31, 2022 | 8.40 Mn |
| Dec 31, 2021 | 4.79 Mn |
API Access
Coya Therapeutics Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=COYA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "COYA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=COYA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();